Clinical Trials Directory

Trials / Unknown

UnknownNCT03891394

Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

Prognostic Value of Human Epididymis Protein 4 (HE4) for Persistent Proteinuria in Women With Severe Preeclampsia / HELLP Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers

Summary

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHuman epididymis protein 4Human epididymis protein 4 serum level in predicting persistent proteniuria

Timeline

Start date
2019-04-01
Primary completion
2019-10-01
Completion
2019-10-30
First posted
2019-03-27
Last updated
2019-03-28

Source: ClinicalTrials.gov record NCT03891394. Inclusion in this directory is not an endorsement.